Our Partners











Our Strategic Plan


THE CANADIAN HEMOPHILIA SOCIETY – WHO WE ARE

The Canadian Hemophilia Society is an organization that works at three levels: nationally, provincially and locally. We have ten provincial chapters across the country. Some of our chapters have additional local structures that we refer to as regions.

Together we are the Canadian Hemophilia Society.








About 300,000 Canadians carry an inherited bleeding disorder gene. One in ten of these people—at least 30,000 Canadians—have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 8,000 people with inherited bleeding disorders are registered in the Canadian network of inherited bleeding disorder comprehensive care clinics.

Inherited bleeding disorders are a family of diseases in which blood proteins or platelets that help the blood to clot are missing or do not function properly, resulting in prolonged bleeding. These conditions include hemophilia A and B, von Willebrand disease, rare factor deficiencies (factors I, II, V, VII, X, XI, XIII), and platelet function disorders. While surface cuts and abrasions can create minor problems, the main risk for children and adults with these disorders is internal bleeding, mainly into muscles and joints or vital organs, which can cause death. For women there are additional risks: heavy menstrual periods, which in the absence of proper diagnosis can lead to reduced quality of life, unnecessary hysterectomies, and the risk of hemorrhaging during childbirth.

For all people with inherited bleeding disorders, prolonged bleeding after injury or surgery can be life threatening.

The Canadian Hemophilia Society (CHS), whose national headquarters are in Montreal, is a national voluntary health charity. Its Board of Directors is made up of 18 individuals designated by the organization’s 10 provincial chapters, up to 4 directors-at-large, a medical advisor and a youth representative. Each provincial chapter in turn is managed by its own Board of Directors. Many chapters are separately incorporated and have their own charitable registrations. Three provinces—Quebec, Ontario and Manitoba—currently have offices with permanent staff. All chapters work in accordance with CHS by-laws and conform to national policies. The national organization and its 10 chapters share a common vision and mission. The CHS has approximately 300 active volunteers across the country.

The CHS is affiliated with the World Federation of Hemophilia, which is officially recognized by the World Health Organization. We work in collaboration with health care providers in Canada’s 25 inherited bleeding disorder comprehensive care clinics, the blood system operators (Canadian Blood Services and Héma-Québec), the Network of Rare Blood Disorder Organizations, the hepatitis C community, the AIDS community, and others who share our common interests.

Our Mission

The Canadian Hemophilia Society is committed to improve the health and quality of life of all people with inherited bleeding disorders and ultimately to find a cure.




Our Vision

A world free from the pain and suffering of inherited bleeding disorders.




The people we serve




The Canadian Hemophilia Society provides information, programs and services to…

  • people with hemophilia, von Willebrand disease, rare factor deficiencies and inherited platelet disorders
  • their families and friends
  • the health care providers in the Canadian network of inherited bleeding disorder comprehensive care clinics
  • the patients’ community (daycare workers, teachers, employers…)
  • the health care providers (primary care practitioners, dentists, specialists…) who may provide care for people with inherited bleeding disorders or who may come into contact with those who remain undiagnosed.




Our Values

The Canadian Hemophilia Society is committed to the following values:

Inclusiveness
By providing information, programs and services to all people with inherited bleeding disorders of all ages and their families in both English and French.

Connectedness
By being well connected to our grassroots community.

Advocacy
By actively representing people with inherited bleeding disorders to improve their quality of life while working towards a cure.

Excellence
By achieving quality, efficiency and innovation while remaining open to change.

Integrity
By acting honestly, responsibly, openly and accountably.

Respect
By treating the people with whom we interact with dignity, fairness and compassion.

Collaboration
By fostering meaningful and collegial relations, and strong partnerships among our diverse stakeholders.


Our Goals

Care and Treatment
Achieve optimal comprehensive care for all people with inherited bleeding disorders.

Awareness
Raise awareness among people with inherited bleeding disorders, their immediate communities and health care providers.

Research
Promote and fund research to improve treatment and ultimately to find a cure.

Education and Support
Provide effective delivery of information and support to patients and their families across Canada in both English and French.

Safe and Secure Supply
Advocate for access to a secure supply of the safest and most efficacious therapies for the treatment of inherited bleeding disorders.

Our Governance Priorities

A Cohesive Organization
Build a cohesive organization through a combination of strong, effective chapters and better collaboration between chapters and the national organization.

Increased Membership
Increase membership in both the chapters and the national organization.

A Culture of Philanthropy
Develop a culture of philanthropy among the expanded membership so as to be able to achieve the mission and goals of the organization.

Our Global Responsibility

While the primary mission of the Canadian Hemophilia Society is to work within our own borders on behalf of Canadians, this strategic plan recognizes our responsibility to the global bleeding disorder community.

Canadians with inherited bleeding disorders enjoy access to the most advanced therapies in optimal quantities. Our comprehensive care clinics provide a high standard of care. Such is not the case around the world where 75% of people with hemophilia do not have access to safe factor therapy and highly trained health care providers. Life expectancy remains less than 20 years on average and these short lives are filled with pain and suffering.

The CHS, as a well-developed patient association, acknowledges its responsibility to work with the World Federation of Hemophilia to further its mission of TREATMENT FOR ALL.